Zenotech Laboratories Ltd.
Snapshot View

57.45 -1.75 ▼-3.0%

30 September 2022, 12:38:00 PM
Volume: 6,287

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://zenotechlab.com
Market Cap 360.08 Cr.
Enterprise Value(EV) 363.64 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 3.68 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 16.04 Trailing Twelve Months Ending 2022-06
Industry PE 31.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 12.19 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.84 Calculated using Price: 59.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 6.10 Cr. 61,030,568 Shares
FaceValue 10
Company Profile
Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.96%
1 Week
-2.13%
1 Month
-1.20%
3 Month
+1.95%
6 Month
+14.67%
1 Year
+21.85%
2 Year
+73.83%
5 Year
+32.68%
10 Year
+75.69%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -65.67 -155.73 -7.73 24.35 -2.48
Return on Capital Employed (%) -48.47 -39.28 -61.52 -65.68 -61.88 -5.95 18.32 0.48
Return on Assets (%) -37.69 -33.32 -45.43 -32.82 -38.33 -17.89 -3.76 12.67 -1.42

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 26 3 -27 -46 -66 42 39 50 48 71
Non Curr. Liab. 1 1 0 0 0 0 0 0 22 -4
Curr. Liab. 40 66 91 99 116 39 45 35 15 16
Minority Int.
Equity & Liab. 67 70 64 53 51 82 85 86 86 82
Non Curr. Assets 62 59 55 50 49 50 65 80 79 74
Curr. Assets 5 11 8 3 2 31 19 6 7 7
Misc. Exp. not W/O
Total Assets 67 70 64 53 51 82 85 86 86 82

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 3 3 4 2 2 11 13 26 22 39
Other Income 0 3 0 0 0 2 5 1 0 1
Total Income 3 5 4 2 2 14 18 27 23 40
Total Expenditure -24 -20 -24 -10 -13 -19 -17 -17 -16 -20
PBIDT -21 -15 -20 -8 -10 -6 1 10 7 20
Interest -1 -5 -7 -8 -8 -2 0 -1 -2 -1
Depreciation -4 -4 -4 -4 -4 -4 -4 -5 -6 -7
Taxation 11
Exceptional Items 2 6
PAT -26 -23 -30 -19 -20 -12 -3 11 -1 22
Adjusted EPS -7 -6 -8 -5 -5 -2 -1 2 0 4

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -2 -10 -24 -8 -5 2 -16 -14 11 6
Cash Fr. Inv. 0 0 -1 0 6 -1 -3 -16 -21 -5
Cash Fr. Finan. 2 10 30 7 -1 -1 47 15 -3 0
Net Change 0 0 5 -1 0 0 28 -15 -12 1
Cash & Cash Eqvt 2 2 6 6 0 0 28 13 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 68.84 68.84 68.84 68.84 68.84 68.84 68.84 68.84 68.84
Public 31.16 31.16 31.16 31.16 31.16 31.16 31.16 31.16 31.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 26 Sep 2022
Closure of Trading Window
This is to inform you that in compliance with the Companys Code of Conduct for Prevention of Insider Trading the window closure for trading by Designated Persons of the Company (along with his/her immediate relatives or any person with whom he/she shares a material financial relationship) shall be with effect from Saturday October 1 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022. The date of the Board Meeting of the Company for declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022 will be intimated in due course.
Sat, 24 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 33rd Annual General Meeting of Zenotech Laboratories Limited held on September 24 2022
Sat, 24 Sep 2022
Chairperson Speech At The 33Rd Annual General Meeting
We are pleased to enclose herewith Chairperson Speech at the 33rd Annual General Meeting held on September 24 2022.

Technical Scans View Details >>

Thu, 29 Sep 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase 2 Years High Increase 2 Years
Wed, 28 Sep 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 223,330.10 944.95 +1.5%
Divi's Laboratories Ltd. 97,819.86 3,699.50 +0.2%
Cipla Ltd. 90,339.79 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. 72,565.89 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. 63,143.03 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. 52,359.20 1,549.70 +0.2%
Abbott India Ltd. 40,610.60 19,207.15 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 57.42 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-06 36.30 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.26 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.37 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-06 50.22 19,207.15 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.46 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-06 4.20 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.58 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.19 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-06 13.62 19,207.15 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 0.00 19,207.15 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,207.15 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 29.95 19,207.15 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,207.15 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 944.95 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,699.50 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,118.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,325.05 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,387.45 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,549.70 +0.2%
Abbott India Ltd. Standalone 2022-03 798.70 19,207.15 +0.1%

FAQ's On Zenotech Laboratories Ltd.

What is Zenotech Laboratorie share price?

Can I buy Zenotech Laboratorie shares now?

What is the Market Cap of Zenotech Laboratorie?

What are the key metrics to analyse Zenotech Laboratorie?

What is the 52 Week High and Low of Zenotech Laboratorie?

What is the trend of Zenotech Laboratorie share price?